Pharma & Healthcare
Global Vaccine Adjuvants Market Research Report 2025
- Mar 11, 25
- ID: 27772
- Pages: 88
- Figures: 92
- Views: 11
The global market for Vaccine Adjuvants was valued at US$ 682 million in the year 2024 and is projected to reach a revised size of US$ 1213 million by 2031, growing at a CAGR of 8.7% during the forecast period.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Human Vaccine
Veterinary Vaccine
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
The vaccine adjuvants market is driven by the increasing need for more effective and long-lasting vaccines. Adjuvants are substances added to vaccines to enhance the body’s immune response, making vaccines more effective, especially in cases where the antigen alone may not provide sufficient protection. The growing prevalence of infectious diseases and the rising demand for vaccines to address new and emerging pathogens, such as COVID-19 variants, are fueling the development and adoption of advanced adjuvants. Additionally, ongoing research and development in immunology and biotechnology are leading to the creation of novel adjuvants that improve vaccine efficacy and safety.
One of the main challenges in the vaccine adjuvants market is the complexity and cost associated with developing and producing new adjuvants. The process requires significant investment in research and development, as well as rigorous testing to ensure safety and effectiveness. Additionally, there are regulatory hurdles that must be overcome, as new adjuvants need to meet stringent guidelines before they can be approved for use. Public concerns about vaccine safety and the potential for adverse reactions to adjuvants also pose challenges, as any negative perceptions can impact vaccine acceptance and adoption.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
GSK
CSL Limited
Croda
SEPPIC
Sanofi
Zhifei Biological
Escon
Huanuotai Biological
Rico Bio
SDA BIO
SPI Pharma
Phibro Animal Health
Vertellus
Segment by Type
Emulsion Adjuvants
Mineral Adjuvants
Others
Segment by Application
Human Vaccine
Veterinary Vaccine
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Vaccine Adjuvants Market Overview
1.1 Product Definition
1.2 Vaccine Adjuvants by Type
1.2.1 Global Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Vaccine Adjuvants by Application
1.3.1 Global Vaccine Adjuvants Market Value by Application (2024 VS 2031)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2020-2031
1.4.2 Global Vaccine Adjuvants Sales 2020-2031
1.4.3 Global Vaccine Adjuvants Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
2.7 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
2.8 Global Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Vaccine Adjuvants Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Adjuvants Market Scenario by Region
3.1 Global Vaccine Adjuvants Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine Adjuvants Sales by Region: 2020-2031
3.2.1 Global Vaccine Adjuvants Sales by Region: 2020-2025
3.2.2 Global Vaccine Adjuvants Sales by Region: 2026-2031
3.3 Global Vaccine Adjuvants Revenue by Region: 2020-2031
3.3.1 Global Vaccine Adjuvants Revenue by Region: 2020-2025
3.3.2 Global Vaccine Adjuvants Revenue by Region: 2026-2031
3.4 North America Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine Adjuvants Sales by Country (2020-2031)
3.4.3 North America Vaccine Adjuvants Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine Adjuvants Sales by Country (2020-2031)
3.5.3 Europe Vaccine Adjuvants Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine Adjuvants Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine Adjuvants Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine Adjuvants Sales by Country (2020-2031)
3.7.3 Latin America Vaccine Adjuvants Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine Adjuvants Sales by Type (2020-2031)
4.1.1 Global Vaccine Adjuvants Sales by Type (2020-2025)
4.1.2 Global Vaccine Adjuvants Sales by Type (2026-2031)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2020-2031)
4.2 Global Vaccine Adjuvants Revenue by Type (2020-2031)
4.2.1 Global Vaccine Adjuvants Revenue by Type (2020-2025)
4.2.2 Global Vaccine Adjuvants Revenue by Type (2026-2031)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine Adjuvants Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine Adjuvants Sales by Application (2020-2031)
5.1.1 Global Vaccine Adjuvants Sales by Application (2020-2025)
5.1.2 Global Vaccine Adjuvants Sales by Application (2026-2031)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2020-2031)
5.2 Global Vaccine Adjuvants Revenue by Application (2020-2031)
5.2.1 Global Vaccine Adjuvants Revenue by Application (2020-2025)
5.2.2 Global Vaccine Adjuvants Revenue by Application (2026-2031)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine Adjuvants Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Company Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Croda
6.3.1 Croda Company Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SEPPIC
6.4.1 SEPPIC Company Information
6.4.2 SEPPIC Description and Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Vaccine Adjuvants Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Zhifei Biological
6.6.1 Zhifei Biological Company Information
6.6.2 Zhifei Biological Description and Business Overview
6.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhifei Biological Vaccine Adjuvants Product Portfolio
6.6.5 Zhifei Biological Recent Developments/Updates
6.7 Escon
6.7.1 Escon Company Information
6.7.2 Escon Description and Business Overview
6.7.3 Escon Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Escon Vaccine Adjuvants Product Portfolio
6.7.5 Escon Recent Developments/Updates
6.8 Huanuotai Biological
6.8.1 Huanuotai Biological Company Information
6.8.2 Huanuotai Biological Description and Business Overview
6.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Huanuotai Biological Vaccine Adjuvants Product Portfolio
6.8.5 Huanuotai Biological Recent Developments/Updates
6.9 Rico Bio
6.9.1 Rico Bio Company Information
6.9.2 Rico Bio Description and Business Overview
6.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rico Bio Vaccine Adjuvants Product Portfolio
6.9.5 Rico Bio Recent Developments/Updates
6.10 SDA BIO
6.10.1 SDA BIO Company Information
6.10.2 SDA BIO Description and Business Overview
6.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.10.5 SDA BIO Recent Developments/Updates
6.11 SPI Pharma
6.11.1 SPI Pharma Company Information
6.11.2 SPI Pharma Description and Business Overview
6.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.11.5 SPI Pharma Recent Developments/Updates
6.12 Phibro Animal Health
6.12.1 Phibro Animal Health Company Information
6.12.2 Phibro Animal Health Description and Business Overview
6.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Phibro Animal Health Vaccine Adjuvants Product Portfolio
6.12.5 Phibro Animal Health Recent Developments/Updates
6.13 Vertellus
6.13.1 Vertellus Company Information
6.13.2 Vertellus Description and Business Overview
6.13.3 Vertellus Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vertellus Vaccine Adjuvants Product Portfolio
6.13.5 Vertellus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Adjuvants Industry Chain Analysis
7.2 Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Adjuvants Production Mode & Process Analysis
7.4 Vaccine Adjuvants Sales and Marketing
7.4.1 Vaccine Adjuvants Sales Channels
7.4.2 Vaccine Adjuvants Distributors
7.5 Vaccine Adjuvants Customer Analysis
8 Vaccine Adjuvants Market Dynamics
8.1 Vaccine Adjuvants Industry Trends
8.2 Vaccine Adjuvants Market Drivers
8.3 Vaccine Adjuvants Market Challenges
8.4 Vaccine Adjuvants Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Vaccine Adjuvants by Type
1.2.1 Global Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031)
1.2.2 Emulsion Adjuvants
1.2.3 Mineral Adjuvants
1.2.4 Others
1.3 Vaccine Adjuvants by Application
1.3.1 Global Vaccine Adjuvants Market Value by Application (2024 VS 2031)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2020-2031
1.4.2 Global Vaccine Adjuvants Sales 2020-2031
1.4.3 Global Vaccine Adjuvants Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
2.7 Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
2.8 Global Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Vaccine Adjuvants Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Vaccine Adjuvants Market Scenario by Region
3.1 Global Vaccine Adjuvants Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Vaccine Adjuvants Sales by Region: 2020-2031
3.2.1 Global Vaccine Adjuvants Sales by Region: 2020-2025
3.2.2 Global Vaccine Adjuvants Sales by Region: 2026-2031
3.3 Global Vaccine Adjuvants Revenue by Region: 2020-2031
3.3.1 Global Vaccine Adjuvants Revenue by Region: 2020-2025
3.3.2 Global Vaccine Adjuvants Revenue by Region: 2026-2031
3.4 North America Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Vaccine Adjuvants Sales by Country (2020-2031)
3.4.3 North America Vaccine Adjuvants Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Vaccine Adjuvants Sales by Country (2020-2031)
3.5.3 Europe Vaccine Adjuvants Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Vaccine Adjuvants Sales by Region (2020-2031)
3.6.3 Asia Pacific Vaccine Adjuvants Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Vaccine Adjuvants Sales by Country (2020-2031)
3.7.3 Latin America Vaccine Adjuvants Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2020-2031)
3.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine Adjuvants Sales by Type (2020-2031)
4.1.1 Global Vaccine Adjuvants Sales by Type (2020-2025)
4.1.2 Global Vaccine Adjuvants Sales by Type (2026-2031)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2020-2031)
4.2 Global Vaccine Adjuvants Revenue by Type (2020-2031)
4.2.1 Global Vaccine Adjuvants Revenue by Type (2020-2025)
4.2.2 Global Vaccine Adjuvants Revenue by Type (2026-2031)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
4.3 Global Vaccine Adjuvants Price by Type (2020-2031)
5 Segment by Application
5.1 Global Vaccine Adjuvants Sales by Application (2020-2031)
5.1.1 Global Vaccine Adjuvants Sales by Application (2020-2025)
5.1.2 Global Vaccine Adjuvants Sales by Application (2026-2031)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2020-2031)
5.2 Global Vaccine Adjuvants Revenue by Application (2020-2031)
5.2.1 Global Vaccine Adjuvants Revenue by Application (2020-2025)
5.2.2 Global Vaccine Adjuvants Revenue by Application (2026-2031)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
5.3 Global Vaccine Adjuvants Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Company Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Company Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Croda
6.3.1 Croda Company Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SEPPIC
6.4.1 SEPPIC Company Information
6.4.2 SEPPIC Description and Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Vaccine Adjuvants Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Zhifei Biological
6.6.1 Zhifei Biological Company Information
6.6.2 Zhifei Biological Description and Business Overview
6.6.3 Zhifei Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Zhifei Biological Vaccine Adjuvants Product Portfolio
6.6.5 Zhifei Biological Recent Developments/Updates
6.7 Escon
6.7.1 Escon Company Information
6.7.2 Escon Description and Business Overview
6.7.3 Escon Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Escon Vaccine Adjuvants Product Portfolio
6.7.5 Escon Recent Developments/Updates
6.8 Huanuotai Biological
6.8.1 Huanuotai Biological Company Information
6.8.2 Huanuotai Biological Description and Business Overview
6.8.3 Huanuotai Biological Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Huanuotai Biological Vaccine Adjuvants Product Portfolio
6.8.5 Huanuotai Biological Recent Developments/Updates
6.9 Rico Bio
6.9.1 Rico Bio Company Information
6.9.2 Rico Bio Description and Business Overview
6.9.3 Rico Bio Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Rico Bio Vaccine Adjuvants Product Portfolio
6.9.5 Rico Bio Recent Developments/Updates
6.10 SDA BIO
6.10.1 SDA BIO Company Information
6.10.2 SDA BIO Description and Business Overview
6.10.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.10.5 SDA BIO Recent Developments/Updates
6.11 SPI Pharma
6.11.1 SPI Pharma Company Information
6.11.2 SPI Pharma Description and Business Overview
6.11.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.11.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.11.5 SPI Pharma Recent Developments/Updates
6.12 Phibro Animal Health
6.12.1 Phibro Animal Health Company Information
6.12.2 Phibro Animal Health Description and Business Overview
6.12.3 Phibro Animal Health Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Phibro Animal Health Vaccine Adjuvants Product Portfolio
6.12.5 Phibro Animal Health Recent Developments/Updates
6.13 Vertellus
6.13.1 Vertellus Company Information
6.13.2 Vertellus Description and Business Overview
6.13.3 Vertellus Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Vertellus Vaccine Adjuvants Product Portfolio
6.13.5 Vertellus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Adjuvants Industry Chain Analysis
7.2 Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Adjuvants Production Mode & Process Analysis
7.4 Vaccine Adjuvants Sales and Marketing
7.4.1 Vaccine Adjuvants Sales Channels
7.4.2 Vaccine Adjuvants Distributors
7.5 Vaccine Adjuvants Customer Analysis
8 Vaccine Adjuvants Market Dynamics
8.1 Vaccine Adjuvants Industry Trends
8.2 Vaccine Adjuvants Market Drivers
8.3 Vaccine Adjuvants Market Challenges
8.4 Vaccine Adjuvants Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccine Adjuvants Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccine Adjuvants Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccine Adjuvants Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 18. Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 19. Global Vaccine Adjuvants Sales by Region (2026-2031) & (MT)
Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2026-2031)
Table 21. Global Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccine Adjuvants Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 27. North America Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 28. North America Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 32. Europe Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 33. Europe Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccine Adjuvants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Vaccine Adjuvants Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 42. Latin America Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 43. Latin America Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccine Adjuvants Sales (MT) by Type (2020-2025)
Table 51. Global Vaccine Adjuvants Sales (MT) by Type (2026-2031)
Table 52. Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 53. Global Vaccine Adjuvants Sales Market Share by Type (2026-2031)
Table 54. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccine Adjuvants Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccine Adjuvants Price (USD/Kg) by Type (2020-2025)
Table 59. Global Vaccine Adjuvants Price (USD/Kg) by Type (2026-2031)
Table 60. Global Vaccine Adjuvants Sales (MT) by Application (2020-2025)
Table 61. Global Vaccine Adjuvants Sales (MT) by Application (2026-2031)
Table 62. Global Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 63. Global Vaccine Adjuvants Sales Market Share by Application (2026-2031)
Table 64. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccine Adjuvants Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccine Adjuvants Price (USD/Kg) by Application (2020-2025)
Table 69. Global Vaccine Adjuvants Price (USD/Kg) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. GSK Vaccine Adjuvants Product
Table 74. GSK Recent Developments/Updates
Table 75. CSL Limited Company Information
Table 76. CSL Limited Description and Business Overview
Table 77. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. CSL Limited Vaccine Adjuvants Product
Table 79. CSL Limited Recent Developments/Updates
Table 80. Croda Company Information
Table 81. Croda Description and Business Overview
Table 82. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Croda Vaccine Adjuvants Product
Table 84. Croda Recent Developments/Updates
Table 85. SEPPIC Company Information
Table 86. SEPPIC Description and Business Overview
Table 87. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. SEPPIC Vaccine Adjuvants Product
Table 89. SEPPIC Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Sanofi Vaccine Adjuvants Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Zhifei Biological Company Information
Table 96. Zhifei Biological Description and Business Overview
Table 97. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Zhifei Biological Vaccine Adjuvants Product
Table 99. Zhifei Biological Recent Developments/Updates
Table 100. Escon Company Information
Table 101. Escon Description and Business Overview
Table 102. Escon Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Escon Vaccine Adjuvants Product
Table 104. Escon Recent Developments/Updates
Table 105. Huanuotai Biological Company Information
Table 106. Huanuotai Biological Description and Business Overview
Table 107. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Huanuotai Biological Vaccine Adjuvants Product
Table 109. Huanuotai Biological Recent Developments/Updates
Table 110. Rico Bio Company Information
Table 111. Rico Bio Description and Business Overview
Table 112. Rico Bio Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Rico Bio Vaccine Adjuvants Product
Table 114. Rico Bio Recent Developments/Updates
Table 115. SDA BIO Company Information
Table 116. SDA BIO Description and Business Overview
Table 117. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. SDA BIO Vaccine Adjuvants Product
Table 119. SDA BIO Recent Developments/Updates
Table 120. SPI Pharma Company Information
Table 121. SPI Pharma Description and Business Overview
Table 122. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. SPI Pharma Vaccine Adjuvants Product
Table 124. SPI Pharma Recent Developments/Updates
Table 125. Phibro Animal Health Company Information
Table 126. Phibro Animal Health Description and Business Overview
Table 127. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Phibro Animal Health Vaccine Adjuvants Product
Table 129. Phibro Animal Health Recent Developments/Updates
Table 130. Vertellus Company Information
Table 131. Vertellus Description and Business Overview
Table 132. Vertellus Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Vertellus Vaccine Adjuvants Product
Table 134. Vertellus Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Vaccine Adjuvants Distributors List
Table 138. Vaccine Adjuvants Customers List
Table 139. Vaccine Adjuvants Market Trends
Table 140. Vaccine Adjuvants Market Drivers
Table 141. Vaccine Adjuvants Market Challenges
Table 142. Vaccine Adjuvants Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccine Adjuvants
Figure 2. Global Vaccine Adjuvants Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccine Adjuvants Market Share by Type: 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Vaccine Adjuvants Market Share by Application: 2024 & 2031
Figure 9. Human Vaccine
Figure 10. Veterinary Vaccine
Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vaccine Adjuvants Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vaccine Adjuvants Sales (2020-2031) & (MT)
Figure 14. Global Vaccine Adjuvants Average Price (USD/Kg) & (2020-2031)
Figure 15. Vaccine Adjuvants Report Years Considered
Figure 16. Vaccine Adjuvants Sales Share by Manufacturers in 2024
Figure 17. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vaccine Adjuvants Players: Market Share by Revenue in Vaccine Adjuvants in 2024
Figure 19. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 22. North America Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 26. Europe Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vaccine Adjuvants Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 34. China Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 45. Latin America Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Vaccine Adjuvants by Type (2020-2031)
Figure 55. Global Revenue Market Share of Vaccine Adjuvants by Type (2020-2031)
Figure 56. Global Vaccine Adjuvants Price (USD/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Vaccine Adjuvants by Application (2020-2031)
Figure 58. Global Revenue Market Share of Vaccine Adjuvants by Application (2020-2031)
Figure 59. Global Vaccine Adjuvants Price (USD/Kg) by Application (2020-2031)
Figure 60. Vaccine Adjuvants Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Vaccine Adjuvants Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2024
Table 4. Global Vaccine Adjuvants Sales (MT) of Key Manufacturers (2020-2025)
Table 5. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Vaccine Adjuvants Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 18. Global Vaccine Adjuvants Sales Market Share by Region (2020-2025)
Table 19. Global Vaccine Adjuvants Sales by Region (2026-2031) & (MT)
Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2026-2031)
Table 21. Global Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
Table 23. Global Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Vaccine Adjuvants Revenue Market Share by Region (2026-2031)
Table 25. North America Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 27. North America Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 28. North America Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 32. Europe Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 33. Europe Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Vaccine Adjuvants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Vaccine Adjuvants Sales by Region (2020-2025) & (MT)
Table 37. Asia Pacific Vaccine Adjuvants Sales by Region (2026-2031) & (MT)
Table 38. Asia Pacific Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 42. Latin America Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 43. Latin America Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Vaccine Adjuvants Sales by Country (2020-2025) & (MT)
Table 47. Middle East and Africa Vaccine Adjuvants Sales by Country (2026-2031) & (MT)
Table 48. Middle East and Africa Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Vaccine Adjuvants Sales (MT) by Type (2020-2025)
Table 51. Global Vaccine Adjuvants Sales (MT) by Type (2026-2031)
Table 52. Global Vaccine Adjuvants Sales Market Share by Type (2020-2025)
Table 53. Global Vaccine Adjuvants Sales Market Share by Type (2026-2031)
Table 54. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
Table 57. Global Vaccine Adjuvants Revenue Market Share by Type (2026-2031)
Table 58. Global Vaccine Adjuvants Price (USD/Kg) by Type (2020-2025)
Table 59. Global Vaccine Adjuvants Price (USD/Kg) by Type (2026-2031)
Table 60. Global Vaccine Adjuvants Sales (MT) by Application (2020-2025)
Table 61. Global Vaccine Adjuvants Sales (MT) by Application (2026-2031)
Table 62. Global Vaccine Adjuvants Sales Market Share by Application (2020-2025)
Table 63. Global Vaccine Adjuvants Sales Market Share by Application (2026-2031)
Table 64. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
Table 67. Global Vaccine Adjuvants Revenue Market Share by Application (2026-2031)
Table 68. Global Vaccine Adjuvants Price (USD/Kg) by Application (2020-2025)
Table 69. Global Vaccine Adjuvants Price (USD/Kg) by Application (2026-2031)
Table 70. GSK Company Information
Table 71. GSK Description and Business Overview
Table 72. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 73. GSK Vaccine Adjuvants Product
Table 74. GSK Recent Developments/Updates
Table 75. CSL Limited Company Information
Table 76. CSL Limited Description and Business Overview
Table 77. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 78. CSL Limited Vaccine Adjuvants Product
Table 79. CSL Limited Recent Developments/Updates
Table 80. Croda Company Information
Table 81. Croda Description and Business Overview
Table 82. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 83. Croda Vaccine Adjuvants Product
Table 84. Croda Recent Developments/Updates
Table 85. SEPPIC Company Information
Table 86. SEPPIC Description and Business Overview
Table 87. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 88. SEPPIC Vaccine Adjuvants Product
Table 89. SEPPIC Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Sanofi Vaccine Adjuvants Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Zhifei Biological Company Information
Table 96. Zhifei Biological Description and Business Overview
Table 97. Zhifei Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 98. Zhifei Biological Vaccine Adjuvants Product
Table 99. Zhifei Biological Recent Developments/Updates
Table 100. Escon Company Information
Table 101. Escon Description and Business Overview
Table 102. Escon Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 103. Escon Vaccine Adjuvants Product
Table 104. Escon Recent Developments/Updates
Table 105. Huanuotai Biological Company Information
Table 106. Huanuotai Biological Description and Business Overview
Table 107. Huanuotai Biological Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 108. Huanuotai Biological Vaccine Adjuvants Product
Table 109. Huanuotai Biological Recent Developments/Updates
Table 110. Rico Bio Company Information
Table 111. Rico Bio Description and Business Overview
Table 112. Rico Bio Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 113. Rico Bio Vaccine Adjuvants Product
Table 114. Rico Bio Recent Developments/Updates
Table 115. SDA BIO Company Information
Table 116. SDA BIO Description and Business Overview
Table 117. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 118. SDA BIO Vaccine Adjuvants Product
Table 119. SDA BIO Recent Developments/Updates
Table 120. SPI Pharma Company Information
Table 121. SPI Pharma Description and Business Overview
Table 122. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 123. SPI Pharma Vaccine Adjuvants Product
Table 124. SPI Pharma Recent Developments/Updates
Table 125. Phibro Animal Health Company Information
Table 126. Phibro Animal Health Description and Business Overview
Table 127. Phibro Animal Health Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 128. Phibro Animal Health Vaccine Adjuvants Product
Table 129. Phibro Animal Health Recent Developments/Updates
Table 130. Vertellus Company Information
Table 131. Vertellus Description and Business Overview
Table 132. Vertellus Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 133. Vertellus Vaccine Adjuvants Product
Table 134. Vertellus Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Vaccine Adjuvants Distributors List
Table 138. Vaccine Adjuvants Customers List
Table 139. Vaccine Adjuvants Market Trends
Table 140. Vaccine Adjuvants Market Drivers
Table 141. Vaccine Adjuvants Market Challenges
Table 142. Vaccine Adjuvants Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Vaccine Adjuvants
Figure 2. Global Vaccine Adjuvants Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccine Adjuvants Market Share by Type: 2024 & 2031
Figure 4. Emulsion Adjuvants Product Picture
Figure 5. Mineral Adjuvants Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Vaccine Adjuvants Market Share by Application: 2024 & 2031
Figure 9. Human Vaccine
Figure 10. Veterinary Vaccine
Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Vaccine Adjuvants Market Size (2020-2031) & (US$ Million)
Figure 13. Global Vaccine Adjuvants Sales (2020-2031) & (MT)
Figure 14. Global Vaccine Adjuvants Average Price (USD/Kg) & (2020-2031)
Figure 15. Vaccine Adjuvants Report Years Considered
Figure 16. Vaccine Adjuvants Sales Share by Manufacturers in 2024
Figure 17. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Vaccine Adjuvants Players: Market Share by Revenue in Vaccine Adjuvants in 2024
Figure 19. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 22. North America Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 26. Europe Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 27. Germany Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Vaccine Adjuvants Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
Figure 34. China Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 45. Latin America Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Vaccine Adjuvants by Type (2020-2031)
Figure 55. Global Revenue Market Share of Vaccine Adjuvants by Type (2020-2031)
Figure 56. Global Vaccine Adjuvants Price (USD/Kg) by Type (2020-2031)
Figure 57. Global Sales Market Share of Vaccine Adjuvants by Application (2020-2031)
Figure 58. Global Revenue Market Share of Vaccine Adjuvants by Application (2020-2031)
Figure 59. Global Vaccine Adjuvants Price (USD/Kg) by Application (2020-2031)
Figure 60. Vaccine Adjuvants Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232